Thanks to all who attended the CU Anschutz Innovation Forum
CU Innovations, Startup Toolbox and Academia Industry Alliance (AIA) hosted a 3-day event on June 10-12th that highlighted the diversity of innovation at the University of Colorado Anschutz Medical Campus.
Engaging presentations and panel discussions demystified the innovation journey. Key sessions covered company formation, building inclusive teams and career opportunities. CU researchers, start-ups and industry partners participated and networked at this successful event!
Congratulations to the winners of the Venture Showcase: NowVitals, pitched by Robin Deterding, MD, and Vināśa Oncology, pitched by Sujatha Venkataraman, PhD!
(1/19)
(2/19)
(3/19)
(4/19)
(5/19)
(6/19)
(7/19)
(8/19)
(9/19)
(10/19)
(11/19)
(12/19)
(13/19)
(14/19)
(15/19)
(16/19)
(17/19)
(18/19)
(19/19)
Agenda
Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Yevgeniy Izrayelit PhD
Director of Biology, OnKure Therapeutics
Yevgeniy is the Director of Biology at OnKure Therapeutics. He has previously held drug discovery roles at Genentech and Novartis, focusing on Oncology and Virology. His start in biotech was at ViewPoint Therapeutics, a biotech startup developing a small molecule treatment for cataracts. Yevgeniy's educational background includes a postdoctoral position at Brown University, a PhD in Chemistry and Chemical Biology from Cornell University and a BA in Biochemistry from Vassar College. Outside of drug discovery, Yevgeniy works to foster collaboration in the local biotech community.
Event Sponsors
Thank you to our sponsors for making this forum possible! We are greatly appreciative of your continued support.
PLATINUM SPONSORS:
SPONSORS:
